Niels J M Verstegen

4PUBLICATIONS
14CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2024
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.

Niels J M Verstegen, Ruth R Hagen, Christine Kreher

|Mar 02, 2023
Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates.

Niels J M Verstegen, Sabrina Pollastro, Peter-Paul A Unger

|Jul 15, 2022
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273.

Niels J M Verstegen, Ruth R Hagen, Jet van den Dijssel

|Jun 02, 2021
Minimalistic In Vitro Culture to Drive Human Naive B Cell Differentiation into Antibody-Secreting Cells.

Peter-Paul A Unger, Niels J M Verstegen, Casper Marsman

Pageof 1

Frequent Collaborators

2 joint publications

Carolien E van de Sandt

1 joint publications

Peter-Paul A Unger

1 joint publications

Casper Marsman

1 joint publications

Anja Ten Brinke